Archive
Administration announces regulatory changes in response to COVID-19
On March 30, 2020 it was announced that the Trump
Administration has continued to make regulatory changes to better address the
COVID-19 pandemic. Many of the changes will affect the way DMEPOS suppliers conduct
business, including eliminating several...
Read Full Post
Medicare to revise guidelines for L3960
By Kim Turner, RN, Clinical Consultant
The HCPCS L3960 is defined as a prefabricated shoulder "airplane design" abduction orthosis which includes the elbow wrist hand and fingers. There are adjustable rigid cuffs and joints/components to optimize...
Read Full Post
COVID19: Billing Medicare Part B Drugs to DME MACs and the CR modifier
By Kim Turner, RN, Clinical Consultant
CMS has recently published guidelines
for billing of Part B Drugs to DME MACs During COVID-19 Pandemic. During the
pandemic, the beneficiary will be allowed to obtain amounts of Part B drugs in
excess of the...
Read Full Post
CMS releases COVID-19 Provider Enrollment FAQs
On Sunday, March 22, 2020, CMS released Frequently Asked Questions (FAQs) on Medicare Provider Enrollment Relief related to COV-19. We've highlighted the FAQs specific to DMEPOS Suppliers below. To view the complete list of FAQs, click here.
How...
Read Full Post
CMS taking actions in response to COVID-19 national emergency
As our country continues to respond to the 2019 Novel Coronavirus Disease (COVID-19), CMS has taken aggressive action to ensure Medicare and Medicaid beneficiaries are receiving necessary and prompt care. On March 13, 2020, The Trump Administration announced...
Read Full Post
Performant (RAC Region 5) Halts Auditing During the Covid-19 Emergency
By Sandra Gauron, Appeals Coordinator
It was confirmed today that Performant will be following CMS’s guidance during the Covid-19 emergency and will not be sending out any new Additional Documentation Request (ADR) letters for 30 days beginning...
Read Full Post
March 23, 2020
Documentation
Quick Tip: Proof of Delivery Signature Guidelines during the COVID-19 pandemic
On Friday the DME MACs provided the following update regarding signature guidelines and proof of delivery:
CMS is currently reviewing signature guidelines that have been affected by the COVID-19 pandemic. At this time suppliers should do their...
Read Full Post
Relaxed HIPAA requirements for telehealth encounters during the COVID-19 national emergency
On March 13, 2020, the Trump Administration announced regulatory flexibilities to help healthcare providers and states to respond to and contain the spread of coronavirus. Included in the announcement was that CMS will activate blanket waivers in an...
Read Full Post
March 17, 2020
DME Documentation
New guidance on timing of the 6-month face-to-face encounter and Standard Written Order for PMDs
By Carrie Nienberg, RN, Director of Clinical Operations
Currently, Policy Article A52498, revised on 01/01/20, indicates a face-to-face encounter must occur within six months prior to the order date on the Standard Written Order (SWO). If the beneficiary...
Read Full Post
Avoiding CERT Errors: Tips for ensuring compliance when billing Medicare for a lumbar spinal orthosis (LSO)
By Kim Turner, RN, Clinical Consultant
Medicare coverage requires that the LSO is rigid or
semi-rigid to support a weak or deformed body member or restricting or
eliminating motion in a diseased or injured part of the body.
There are three types...
Read Full Post